Yan Gong
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
-
- Hormonal Regulation and Hypertension
- Diabetes Treatment and Management
Papers in
-
- Hormonal Regulation and Hypertension 36
- Diabetes Treatment and Management 21
-
- Blood Pressure and Hypertension Studies 43
- Co-authors
- Rhonda M. Cooper‐DeHoffCarl J. PepineJulie A. JohnsonTaimour LangaeeEileen HandbergAnthony A. BavryScott J. DenardoAmber L. Beitelshees
- Journals
- Clinical Pharmacology & Therapeutics (10 papers)Journal of the American Heart Association (10 papers)Clinical and Translational Science (9 papers)Hypertension (8 papers)PLoS ONE (8 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Yan Gong
193 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Pharmacology 758
- Endocrinology, Diabetes and Metabolism 1.4k
- Cardiology and Cardiovascular Medicine 1.8k
- Orthopedics and Sports Medicine 249
- Biochemistry 200
Countries citing papers authored by Yan Gong
This map shows the geographic impact of Yan Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Gong more than expected).
Fields of papers citing papers by Yan Gong
This network shows the impact of papers produced by Yan Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Gong. The network helps show where Yan Gong may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Gong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 6 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 25 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 0 | |
| 15 | 2018 | 13 | |
| 16 | 2018 | 16 | |
| 17 | 2016 | 3 | |
| 18 | 2014 | 9 | |
| 19 | 2013 | 27 | |
| 20 | Effects of salmon calcitonin on gene and protein expression of OPG and RANKL in bone marrow cells from ovariectomized rats | 2013 | 1 |
About Yan Gong
Yan Gong is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Pharmacology, Biochemistry and Orthopedics and Sports Medicine, having authored 200 papers that have together received 4.9k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (43 papers), Hormonal Regulation and Hypertension (36 papers), Diabetes Treatment and Management (21 papers), Pharmacogenetics and Drug Metabolism (20 papers), Genetic Associations and Epidemiology (14 papers), Eicosanoids and Hypertension Pharmacology (13 papers), Metabolomics and Mass Spectrometry Studies (12 papers) and Receptor Mechanisms and Signaling (11 papers). The work is most often cited by research in Pharmacology (758 citations), Endocrinology, Diabetes and Metabolism (1.4k citations), Cardiology and Cardiovascular Medicine (1.8k citations), Orthopedics and Sports Medicine (249 citations) and Biochemistry (200 citations). Yan Gong has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Rhonda M. Cooper‐DeHoff, Carl J. Pepine, Julie A. Johnson, Taimour Langaee, Eileen Handberg, Anthony A. Bavry, Scott J. Denardo, Amber L. Beitelshees, John G. Gums and George L. Bakris. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of the American Heart Association, Clinical and Translational Science, Hypertension and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.